Jensen et al., 1941 - Google Patents
Reduction of arterial blood pressure of hypertensive rats by administration of renal extractsJensen et al., 1941
- Document ID
- 6535334611396902814
- Author
- Jensen H
- Corwin W
- Tolksdorf S
- Casey J
- Bamman F
- Publication year
- Publication venue
- The Journal of Pharmacology and Experimental Therapeutics
External Links
Snippet
A method is described for the preparation of renal extracts which are capable of reducing the blood pressure of rats with experimental hypertension. A total dose of 58 grams equivalent of fresh hog kidney, injected intramuscularly twice daily for a period of four days, was found …
- 239000000284 extract 0 title abstract description 15
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BATEMAN et al. | Fatal complications of intensive antibiotic therapy in patients with neoplastic disease | |
| Swingle et al. | The role of the adrenal cortex in physiological processes | |
| Dobbs et al. | Maintenance digoxin after an episode of heart failure: placebo-controlled trial in outpatients. | |
| Matsuda et al. | Reduced fluid volume requirement for resuscitation of third-degree burns with high-dose vitamin C | |
| FRAME et al. | The effects of insulin and anterior pituitary extract on the blood amino nitrogen in eviscerated rats | |
| Perlzweig et al. | Hyperproteinemia associated with multiple myelomas: report of an unusual case | |
| Bligh | The role of the liver and the kidneys in the maintenance of the level of free choline in plasma | |
| Page et al. | Reduction of arterial blood pressure of hypertensive patients and animals with extracts of kidneys | |
| Jensen et al. | Reduction of arterial blood pressure of hypertensive rats by administration of renal extracts | |
| HAKSTIAN et al. | Pharmacological Agents in Experimental Hemorrhagic Shock: A Controlled Comparison of Treatment with Hydralazine, Hydrocortisone, and Levarterenol (l-Norepinephrine) | |
| DE3427797A1 (en) | Cytoprotective effect of prostacyclin derivatives on liver, pancreas gland and kidney | |
| Kahlson | Control of Gastric Secretion | |
| PAGE et al. | The blood pressure reducing property of extracts of kidneys in hypertensive patients and animals | |
| Cummings et al. | CARDIOVASCULAR ACTIONS OF GUANCYDINE IN NORMOTENSIVE AND HYPERTENSIVE ANEMALS | |
| Schaefer et al. | Normalization of elevated prolactin levels in hemodialysis patients on erythropoietin | |
| Dawborn et al. | Persistent postural hypotension due to guanacline | |
| KINNEY et al. | The polyuria of paroxysmal atrial tachycardia | |
| Gale et al. | Primary aldosteronism: a case with severe hypertension | |
| Goldblatt et al. | Studies on Experimental Hypertension: XVII. Experimental Observations on the Treatment of Hypertension | |
| Hiatt et al. | Influence of epinephrine and propranolol on transmembrane K transfer in anuric dogs with hyperkalemia. | |
| Botticelli et al. | Mechanisms of pressor amine dependence | |
| NL8200509A (en) | MEDICINAL PRODUCT FOR ALLERGY DISEASES, IMMUNE COMPLEX DISEASES AND TUMORS; METHOD FOR TREATING PATIENTS SUFFERING FROM THIS | |
| Larochelle et al. | Minoxidil in severe hypertension | |
| Del Greco et al. | Hypertension in terminal renal failure: Observations pre and post bilateral nephrectomy | |
| Davis et al. | The combination of sympathectomy and thiocyanates in the treatment of experimental and essential, or high diastolic, hypertension |